Is Pseudoephedrine safe for dogs and cats?
High risk for petsPseudoephedrine is a sympathomimetic amine found in OTC cold and decongestant products (Sudafed, combination cold medications). Dogs are highly sensitive to pseudoephedrine toxicity. The toxic dose in dogs is approximately 1–2 mg/kg, and many household decongestant tablets contain 30–60 mg per dose. A 60 mg tablet represents a potentially toxic dose for a 30–60 kg dog and a clearly dangerous dose for small dogs. Pseudoephedrine's mechanism is indirect sympathomimetic action — it displaces norepinephrine from presynaptic vesicles and inhibits reuptake, causing catecholamine storm. Clinical signs in dogs occur rapidly (within 30–60 minutes) and include severe tachycardia (heart rates 200–300 bpm), hypertension, hyperthermia, tremors, agitation, mydriasis, and seizures. Ventricular arrhythmias and sudden cardiac death occur in severe cases. Management includes decontamination if early, sedation/anxiolytics (acepromazine contraindicated due to α-blockade unmasking tachycardia; prefer butorphanol or diazepam), and cardiovascular stabilization. Pseudoephedrine toxicosis is a veterinary emergency requiring aggressive monitoring. The Combat Methamphetamine Epidemic Act (2006) restricts pseudoephedrine sales in the US, but it remains widely available behind pharmacy counters.
What is pseudoephedrine?
The IUPAC name is (1S,2S)-2-(methylamino)-1-phenylpropan-1-ol.
Also known as: (1S,2S)-2-(methylamino)-1-phenylpropan-1-ol, d-Pseudoephedrine, Isoephedrine, trans-Ephedrine.
- IUPAC name
- (1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
- CAS number
- 90-82-4
- Molecular formula
- C10H15NO
- Molecular weight
- 165.23 g/mol
- SMILES
- CC(C(C1=CC=CC=C1)O)NC
- PubChem CID
- 7028
Risk for dogs
High riskPseudoephedrine is a sympathomimetic amine found in OTC cold and decongestant products (Sudafed, combination cold medications). Dogs are highly sensitive to pseudoephedrine toxicity. The toxic dose in dogs is approximately 1–2 mg/kg, and many household decongestant tablets contain 30–60 mg per dose. A 60 mg tablet represents a potentially toxic dose for a 30–60 kg dog and a clearly dangerous dose for small dogs. Pseudoephedrine's mechanism is indirect sympathomimetic action — it displaces norepinephrine from presynaptic vesicles and inhibits reuptake, causing catecholamine storm. Clinical signs in dogs occur rapidly (within 30–60 minutes) and include severe tachycardia (heart rates 200–300 bpm), hypertension, hyperthermia, tremors, agitation, mydriasis, and seizures. Ventricular arrhythmias and sudden cardiac death occur in severe cases. Management includes decontamination if early, sedation/anxiolytics (acepromazine contraindicated due to α-blockade unmasking tachycardia; prefer butorphanol or diazepam), and cardiovascular stabilization. Pseudoephedrine toxicosis is a veterinary emergency requiring aggressive monitoring. The Combat Methamphetamine Epidemic Act (2006) restricts pseudoephedrine sales in the US, but it remains widely available behind pharmacy counters.
Risk for cats
High riskCats are also highly sensitive to pseudoephedrine toxicity, experiencing the same sympathomimetic toxidrome as dogs. Cats typically encounter pseudoephedrine through ingestion of dropped tablets or by chewing packaging containing cold medication. Clinical signs in cats include severe tachycardia, hypertension, hyperthermia, agitation, vocalization, muscle tremors, and seizures. The narrow therapeutic index and rapid onset of cardiovascular effects make pseudoephedrine a veterinary emergency in cats. Management parallels that for dogs: early decontamination if safe (careful in agitated/seizing animals), cardiovascular monitoring, sedation, and treatment of hyperthermia. Prognosis is good with prompt treatment but poor if cardiovascular compromise or refractory seizures develop. Pet owners should store all cold medications — including combination products with pseudoephedrine — in secured locations inaccessible to pets.
Regulatory consensus
5 regulatory and scientific bodies have classified Pseudoephedrine. The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| EPA CTX / Genetox | — | Genotoxicity: negative (Ames: negative, 0 positive / 1 negative reports) | |
| EPA CTX / Genetox | — | Genotoxicity: negative (Ames: negative, 0 positive / 1 negative reports) | |
| EPA CTX / Skin-Eye | — | eye irritation: in vivo: Studies Indicate No Significant Irritation (score: low) | |
| EPA CTX / Skin-Eye | — | skin irritation: in vivo: Studies Indicate No Significant Irritation (score: low) | |
| EPA CTX / Skin-Eye | — | skin sensitisation: in vivo (LLNA): High Frequency of Sensitization (score: high) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where pets encounter pseudoephedrine
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Pseudoephedrine:
-
Therapeutic alternatives (consult prescriber)
Trade-offs: Drug-specific. Cannot substitute without medical guidance.Relative cost: 1.2-2×
Frequently asked questions
Is pseudoephedrine safe for pets?
Pseudoephedrine is a sympathomimetic amine found in OTC cold and decongestant products (Sudafed, combination cold medications). Dogs are highly sensitive to pseudoephedrine toxicity. The toxic dose in dogs is approximately 1–2 mg/kg, and many household decongestant tablets contain 30–60 mg per dose. A 60 mg tablet represents a potentially toxic dose for a 30–60 kg dog and a clearly dangerous dose for small dogs. Pseudoephedrine's mechanism is indirect sympathomimetic action — it displaces norepinephrine from presynaptic vesicles and inhibits reuptake, causing catecholamine storm. Clinical signs in dogs occur rapidly (within 30–60 minutes) and include severe tachycardia (heart rates 200–300 bpm), hypertension, hyperthermia, tremors, agitation, mydriasis, and seizures. Ventricular arrhythmias and sudden cardiac death occur in severe cases. Management includes decontamination if early, sedation/anxiolytics (acepromazine contraindicated due to α-blockade unmasking tachycardia; prefer butorphanol or diazepam), and cardiovascular stabilization. Pseudoephedrine toxicosis is a veterinary emergency requiring aggressive monitoring. The Combat Methamphetamine Epidemic Act (2006) restricts pseudoephedrine sales in the US, but it remains widely available behind pharmacy counters.
What products contain pseudoephedrine?
Pseudoephedrine appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
Why do regulators disagree about pseudoephedrine?
Pseudoephedrine has been classified by 5 agencies including EPA CTX / Genetox, EPA CTX / Genetox, EPA CTX / Skin-Eye, EPA CTX / Skin-Eye, EPA CTX / Skin-Eye, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.
See Pseudoephedrine in the pets app
Look up products containing pseudoephedrine, compare to alternatives, and explore the full data record.
Open in pets View raw API dataSources (3)
- US FDA: Pseudoephedrine OTC Status, Combat Methamphetamine Epidemic Act Regulations, and Labeling Guidance (2006) — regulatory
- ASPCA Animal Poison Control Center: Pseudoephedrine and Sympathomimetic Toxicosis in Dogs and Cats — Clinical Signs, Management, and Prognosis (2023) — veterinary
- Plumb's Veterinary Drug Handbook (10th ed.) — Pseudoephedrine: Sympathomimetic Toxicosis in Companion Animals (2023) — veterinary
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →